Table 2.
Sample sizes for a test-negative case-control study design, assuming 80% power to detect an OR=1-VE, by per cent coverage among controls (those testing negative) and number of controls per case, with a two-sided alpha=0.05 test.
Vaccine efficacy (VE; %) | Coverage (% vaccinated among controls) | Sample size (no. of cases) by number of controls per case | |||
1 | 2 | 3 | 4 | ||
90 | 5 | 210 | 171 | 157 | 149 |
10 | 103 | 84 | 77 | 73 | |
20 | 50 | 40 | 37 | 35 | |
30 | 32 | 26 | 23 | 22 | |
50 | 19 | 15 | 13 | 12 | |
70 | 14 | 11 | 9 | 9 | |
70 | 5 | 418 | 333 | 303 | 288 |
10 | 211 | 167 | 152 | 144 | |
20 | 107 | 84 | 76 | 72 | |
30 | 74 | 57 | 52 | 49 | |
50 | 50 | 38 | 34 | 32 | |
70 | 46 | 34 | 30 | 28 | |
50 | 5 | 962 | 749 | 677 | 641 |
10 | 492 | 383 | 345 | 326 | |
20 | 260 | 201 | 181 | 171 | |
30 | 186 | 143 | 128 | 120 | |
50 | 137 | 103 | 92 | 86 | |
70 | 141 | 105 | 92 | 86 | |
30 | 5 | 3070 | 2350 | 2109 | 1989 |
10 | 1593 | 1218 | 1092 | 1029 | |
20 | 866 | 659 | 590 | 555 | |
30 | 638 | 483 | 432 | 406 | |
50 | 499 | 375 | 334 | 313 | |
70 | 553 | 412 | 364 | 340 |